Simplify Diagnosis of Invasive Aspergillosis
New Lateral Flow Assay Provides Quick and Easy Results
The new IMMY sōna Aspergillus Galactomannan Lateral Flow Assay is now available in the UK exclusively from Alpha Laboratories Ltd. This immunochromatographic test system for the qualitative detection of Aspergillus Galactomannan in serum and BAL samples, provides a simplified test procedure and rapid turnaround time for the diagnosis of invasive aspergillosis.
Aspergillus GM LFA provides high sensitivity and specificity, plus the easy to use format and rapid 30 minute test time eliminates the need for batch testing.
When used in conjunction with other diagnostic procedures such as microbiological culture, histological examination of biopsy samples and radiographic evidence, the Aspergillus GM LFA aids the diagnosis of aspergillosis. Improved diagnostics could lead to better treatment outcomes and higher survival rates!
Over 30 million people are at risk of invasive aspergillosis each year and over 300,000 patients develop it annually. The disease is common in high risk patients with: haematological malignancies, chemotherapy-induced neutropenia, allogeneic HSCT (stem cell transplant) and who have undergone solid organ transplant (primarily lung).
Please visit www.alphalabs.co.uk/af2003 for any further information or to request a sample of Aspergillus GM LFA.
Date Published: 23rd July 2018
Source article link: Alpha Laboratories Ltd